JD Health International Inc. (JD Health) filed its Monthly Return for the period ended 30 April 2026, confirming a stable share structure and full compliance with Hong Kong public-float rules.

Authorised Capital • Authorised share capital stood at 100.00 billion ordinary shares with a par value of USD 0.0000005 each, translating to USD 50,000—unchanged from the previous month.

Issued Shares and Treasury Position • Issued shares remained at 3.21 billion, while treasury shares stayed at zero. • No new shares were issued and no shares were repurchased or cancelled during the month. • The company affirmed compliance with the 25 percent minimum public-float threshold under Main Board Rule 13.32B.

Equity Incentive Schemes • Pre-IPO ESOP: Outstanding options fell to 9.43 million after 1.42 million options lapsed and a net adjustment of 0.32 million classified as “others”. No new grants were made, and exercises were settled with existing shares held in trust, generating only USD 0.16 in proceeds. • Post-IPO Share Option Scheme: No outstanding options at month-end, with capacity for up to 312.71 million shares. • Post-IPO Share Award Scheme: Up to 15.52 million shares remain available for future awards; no activity occurred in April.

Warrants, Convertibles, and Other Agreements • The company reported no warrants, convertible securities, or additional share-issuance arrangements beyond the stated schemes.

Overall, JD Health’s authorised and issued share capital, treasury-share status, and public-float position were unchanged in April 2026, indicating a stable equity base during the period.